CENTER ID: | NafoA.01063.a |
ORGANISM: | Naegleria fowleri ATCC 30863 |
ASSOCIATED DISEASE: | |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.01063.a.B11.GE40615 | Full length(NafoA.01063.a) | 1 | 201 |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
NafoA.01063.a.B11.PS38271 | Full length(NafoA.01063.a) | 1 | 201 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | AmoebaDB:NF0110670 |
HARVESTED ON: | 10/18/2016 |
SEQUENCED ON: | 10/19/2016 |
EXPECTED MW: | 23kDa |
OBSERVED MW: | 23kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Moderate Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |
PURIFICATION DATe: | 5/2/2017 |
CONCENTRATION: | 29.2mg/ml |
OBSERVED MW: | 25kDa |
EXPRESSION LEVEL: | Low Expression |
PROTEIN PURIFICATION BUFFER: | SEC Buffer: 20mM HEPES pH 7.0, 300mM NaCl, 5% glycerol, 1mM TCEP |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
VIAL COUNT (approx.): | 2 |
VIAL VOLUME: | 200µl |
PERCENT IDENTITY: | 100 |
PERCENT COVERAGE: | 100 |